Young-Hwa Chung

Prof. Dr. Young-Hwa Chung

Professor
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2012 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
ICIl-Rae Cho
Il-Rae Cho
MOMyungju Oh
Myungju Oh
SKSang Seok Koh
Sang Seok Koh
WMWaraporn Malilas
Waraporn Malilas
RSRatakorn Srisuttee
Ratakorn Srisuttee
YCYoung-Hwa Chung
Young-Hwa Chung
We have previously shown that hepatitis B virus (HBV) protein X (HBX), a regulatory protein of HBV, activates Stat1, leading to type I interferon (IFN) production. Type I IFN secreted from HBX-expressing hepatic cells enforces antiviral signals through its binding to the cognate type I IFN receptor. We therefore investigated how cells handle this detrimental situation. Interestingly, compared to Chang cells stably expressing an empty vector (Chang-Vec), Chang cells stably expressing HBX (Chang-HBX) showed lower levels of IFN-α receptor 1 (IFNAR1) protein, a subunit of type I IFN receptor. The levels of IFNAR1 transcripts detected in Chang-HBX cells were lower than the levels in Chang-Vec cells, indicating that HBX regulates IFNAR1 at the transcriptional level. Moreover, we observed that HBX induced the translocation of IFNAR1 to the cytoplasm. Consistent with these observations, HBX also downregulated Tyk2, which is required for the stable expression of IFNAR1 on the cell surface. Eventually, Chang-HBX cells consistently maintained a lower level of IFNAR1 expression and displayed no proper response to IFN-α, while Chang-Vec cells exhibited a proper response to IFN-α treatment. Taken together, we propose that HBX downregulates IFNAR1, leading to the avoidance of extracellular IFN-α signal transduction.

16 January 2015 in Marine Drugs
Verified
Journal Article
Open access
PDF file
HLHyun-Young Lee
Hyun-Young Lee
KCKyu Jin Chung
Kyu Jin Chung
IHIn Hyun Hwang
In Hyun Hwang
JGJungsuk Gwak
Jungsuk Gwak
SPSeoyoung Park
Seoyoung Park
SOSangtaek Oh
Sangtaek Oh
The tumor suppressor, p53, plays an essential role in the cellular response to stress through regulating the expression of genes involved in cell cycle arrest, apoptosis and autophagy. Here, we used a cell-based reporter system for the detection of p53 response transcription to identify the marine sponge metabolites, ilimaquinone and ethylsmenoquinone, as activators of the p53 pathway. We demonstrated that ilimaquinone and ethylsmenoquinone efficiently stabilize the p53 protein through promotion of p53 phosphorylation at Ser15 in both HCT116 and RKO colon cancer cells. Moreover, both compounds upregulate the expression of p21WAF1/CIP1, a p53-dependent gene, and suppress proliferation of colon cancer cells. In addition, ilimaquinone and ethylsmenoquinone induced G2/M cell cycle arrest and increased caspase-3 cleavage and the population of cells that positively stained with Annexin V-FITC, both of which are typical biochemical markers of apoptosis. Furthermore, autophagy was elicited by both compounds, as indicated by microtubule-associated protein 1 light chain 3 (LC3) puncta formations and LC3-II turnover in HCT116 cells. Our findings suggest that ilimaquinone and ethylsmenoquinone exert their anti-cancer activity by activation of the p53 pathway and may have significant potential as chemo-preventive and therapeutic agents for human colon cancer.

1 January 2011 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
ICIl-Rae Cho
Il-Rae Cho
SKSang Seok Koh
Sang Seok Koh
HMHye-Jin Min
Hye-Jin Min
SKSu Jin Kim
Su Jin Kim
YLYangsoon Lee
Yangsoon Lee
YCYoung-Hwa Chung
Young-Hwa Chung
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.

10 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
SKSirichat Kaowinn
Sirichat Kaowinn
JKJeonghyo Kim
Jeonghyo Kim
JLJaebeom Lee
Jaebeom Lee
DSDong Hoon Shin
Dong Hoon Shin
CKChi-Dug Kang
Chi-Dug Kang
YCYoung-Hwa Chung
Young-Hwa Chung
Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF- signaling

12 September 2018 in Oncology Reports
Verified
Journal Article
Open access
PDF file
SKSirichat Kaowinn
Sirichat Kaowinn
CKChutima Kaewpiboon
Chutima Kaewpiboon
SKSang Seok Koh
Sang Seok Koh
OKOliver H. Krämer
Oliver H. Krämer
YCYoung-Hwa Chung
Young-Hwa Chung
Our previous studies have shown that the novel oncogene, cancer upregulated gene 2 (CUG2), activates STAT1, which is linked to anticancer drug resistance, induces epithelial‑mesenchymal transition (EMT) and cancer stem cell‑like phenotypes as determined by MTT, migration and sphere formation assays. We thus aimed to ascertain whether the activation of STAT1 by CUG2 is involved in these malignant phenotypes besides drug resistance. Here, we showed that STAT1 suppression decreased the expression of N‑cadherin and vimentin, biomarkers of EMT, which led to inhibition of the migration and invasion of human lung A549 cancer cells stably expressing CUG2, but did not recover E‑cadherin expression. STAT1 siRNA also diminished CUG2‑induced TGF‑β signaling, which is critical in EMT, and TGF‑β transcriptional activity. Conversely, inhibition of TGF‑β signaling reduced phosphorylation of STAT1, indicating a crosstalk between STAT1 and TGF‑β signaling. Furthermore, STAT1 silencing diminished sphere formation, which was supported by downregulation of stemness‑related factors such as Sox2, Oct4, and Nanog. Constitutive suppression of STAT1 also inhibited cell migration, invasion and sphere formation. As STAT1 acetylation counteracts STAT1 phosphorylation, acetylation of STAT1 by treatment with trichostatin A, an inhibitor of histone deacetylases (HDACs), reduced cell migration, invasion, and sphere formation. As HDAC4 is known to target STAT1, its role was investigated under CUG2 overexpression. HDAC4 suppression resulted in inhibition of cell migration, invasion, and sphere formation as HDAC4 silencing hindered TGF‑β signaling and decreased expression of Sox2 and Nanog. Taken together, we suggest that STAT1‑HDAC4 signaling induces malignant tumor features such as EMT and sphere formation in CUG2‑overexpressing cancer cells.

3 August 2017 in Cellular Oncology
Verified
Journal Article
Closed access
PDF file
SKSirichat Kaowinn
Sirichat Kaowinn
SJSeung Won Jun
Seung Won Jun
CKChang Seok Kim
Chang Seok Kim
DSDong-Myeong Shin
Dong-Myeong Shin
YHYoon-Hwae Hwang
Yoon-Hwae Hwang
YCYoung-Hwa Chung
Young-Hwa Chung